← Leaderboards
Andrew T Kent
Icahn School Of Medicine At Mount Sinai
$123,147
Attributed
$123,147
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $48.1K · FY2013–15$50K$37.5K$25K$12.5K$0
'13
'14
'15
Funding mix
By agency
NIH$123,147 · 1
By mechanism
F30$123,147 · 1
Top collaborators
No co-investigators on record.
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Jeffrey Ohmann Bush$16,044,315
- Brian D Brown$18,622,393
- Li Sun$3,167,852
- Dolores Hambardzumyan$10,720,002
- Paul J Kenny$51,539,568
Others in their field
Top investigators on “Agonist”
- John M Lachin · George Washington University$118,921,924
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- Alan G. Barbour · University Of California Irvine$40,092,035
- Alexandros Makriyannis · University Of Connecticut Storrs$29,942,402
- Scott T Weiss · University Of California, San Diego$28,624,344
- John Didsbury · T3d Therapeutics, Inc.$25,150,614
Research focus
AgonistAdaptive ImmunityAreaBacteriaAntigen PresentationBiologyC57bl/6 MouseCancer ModelCaspaseCaspase-1BaseCell Culture TechniquesCell ProliferationCellsCell TransformationCell TypeColitisColorectal CancerComplexCytokineDendritic CellsDesignCd8b1 GeneFamily Member
Grant awards (3)
Consequences of NLRC4/NAIP5 Inflammasome Signaling on Adaptive Immunity and Tumor$48,120
F30 · FY2015 · CA · contact PI
Consequences of NLRC4/NAIP5 Inflammasome Signaling on Adaptive Immunity and Tumor$37,121
F30 · FY2014 · CA · contact PI
Consequences of NLRC4/NAIP5 Inflammasome Signaling on Adaptive Immunity and Tumor$37,906
F30 · FY2013 · CA · contact PI